How many insider trades does FilingIQ track for FIXX?

FilingIQ tracks 179 Form 4 insider transactions for FIXX (Homology Medicines, Inc.), covering filings from Apr 2, 2018 onwards. 0 of those were filed in the last 90 days.

Are FIXX insiders net buyers or net sellers?

Across the full Form 4 history for FIXX, 6 transactions (3%) were open-market purchases and 106 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FIXX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FIXX in?

Homology Medicines, Inc. (FIXX) is classified in the Healthcare sector, specifically Biotechnology.

FIXX insider trading

NYSE American Healthcare

Homology Medicines, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

179

Last 90 days

Buys / sells

3% / 59%

Market cap

—

About Homology Medicines, Inc.

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Company website: www.homologymedicines.com

FIXX insider activity at a glance

FilingIQ has scored 179 insider transactions for FIXX since Apr 2, 2018. The most recent filing in our index is dated Mar 25, 2024.

Across the full history, 6 open-market purchases and 106 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FIXX insider trades is 59.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FIXX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 795

UNITED THERAPEUTICS Corp

KYMR 165

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

Frequently asked

How many insider trades does FilingIQ track for FIXX?: FilingIQ tracks 179 Form 4 insider transactions for FIXX (Homology Medicines, Inc.), covering filings from Apr 2, 2018 onwards. 0 of those were filed in the last 90 days.
Are FIXX insiders net buyers or net sellers?: Across the full Form 4 history for FIXX, 6 transactions (3%) were open-market purchases and 106 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FIXX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FIXX in?: Homology Medicines, Inc. (FIXX) is classified in the Healthcare sector, specifically Biotechnology.

Methodology & sources

Every FIXX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.